BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value: $2.639B (100.0% shares, 0.0% debt)

Holdings (7)

— CEREVAL THERAPEUTICS HOLDINGS, INC 38.1%

Value $1.005B Shares 60,632,356 Est. Cost $16.58 Unrealized —

SGRY SURGERY PARTNERS INC 29.1%

Value $767M Shares 26,455,651 Est. Cost $14.30 Unrealized +74.0%

— MICHAELS COS INC 26.0%

Value $687M Shares 52,798,929 Est. Cost $17.48 Unrealized —

IQV IQVIA HLDGS INC 4.2%

Value $111M Shares 617,484 Est. Cost $101.80 Unrealized +65.5%

ADV ADVANTAGE SOLUTIONS INC. 1.4%

Value $38.06M Shares 2,890,000 Est. Cost $10.52 Unrealized 0.0%

— VERITIV CORP 1.1%

Value $28.77M Shares 1,383,840 Est. Cost $50.06 Unrealized —

— ATENTO S A 0.1%

Value $2.129M Shares 156,574 Est. Cost $10.45 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	CEREVAL THERAPEUTICS HOLDINGS, INC	60,632,356	$1.005B	38.1%	$16.58	—	COM	15678U128
SGRY	SURGERY PARTNERS INC	26,455,651	$767M	29.1%	$14.30	+74.0%	COM	86881A100
—	MICHAELS COS INC	52,798,929	$687M	26.0%	$17.48	—	COM	59408Q106
IQV	IQVIA HLDGS INC	617,484	$111M	4.2%	$101.80	+65.5%	COM	46266C105
ADV	ADVANTAGE SOLUTIONS INC.	2,890,000	$38.06M	1.4%	$10.52	0.0%	COM CL A	00791N102
—	VERITIV CORP	1,383,840	$28.77M	1.1%	$50.06	—	COM	923454102
—	ATENTO S A	156,574	$2.129M	0.1%	$10.45	—	SHS	L0427L105